ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,35049
0,00%
Bitcoin
66.455,58
0,40%
Brent Oil
82,275
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Synthorx Inc (THOR)

  7. Synthorx Inc (THOR) Notícias

THOR

Synthorx (THOR)

Synthorx Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:THOR
DataHoraFonteTítuloCódigoCompanhia
22/12/202112:34TipRanksThor Industries to Buyback $250M Shares; Shares RiseNASDAQ:THORSynthorx Inc
18/03/202015:03Edgar (US Regulatory)Unknown (sec Staff)NASDAQ:THORSynthorx Inc
14/02/202011:30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:THORSynthorx Inc
03/02/202009:31Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:THORSynthorx Inc
24/01/202020:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:THORSynthorx Inc
24/01/202019:54Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:THORSynthorx Inc
23/01/202018:28Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:THORSynthorx Inc
23/01/202018:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:THORSynthorx Inc
23/01/202010:58Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:THORSynthorx Inc
23/01/202009:04Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:THORSynthorx Inc
23/01/202009:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:THORSynthorx Inc
06/01/202013:07PR Newswire (US)Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the FirmNASDAQ:THORSynthorx Inc
27/12/201919:28Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:THORSynthorx Inc
27/12/201918:31Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:THORSynthorx Inc
23/12/201918:52Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:THORSynthorx Inc
12/12/201916:32PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Synthorx, Inc.NASDAQ:THORSynthorx Inc
11/12/201909:32Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:THORSynthorx Inc
10/12/201905:02Dow Jones NewsMerck, Sanofi Push To Add Cancer Drugs -- WSJNASDAQ:THORSynthorx Inc
10/12/201905:02Dow Jones NewsSanofi to Get Out of Diabetes Research -- WSJNASDAQ:THORSynthorx Inc
09/12/201921:16Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 4th UpdateNASDAQ:THORSynthorx Inc
09/12/201919:13Dow Jones NewsSanofi, Maker of World's Biggest Insulin, to Exit Diabetes ResearchNASDAQ:THORSynthorx Inc
09/12/201918:37Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 3rd UpdateNASDAQ:THORSynthorx Inc
09/12/201916:33Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 2nd UpdateNASDAQ:THORSynthorx Inc
09/12/201912:28Dow Jones NewsSynthorx Shares Almost Triple After Sanofi Buyout OfferNASDAQ:THORSynthorx Inc
09/12/201909:23Dow Jones NewsSynthorx Shares Up 165% After Sanofi Buyout OfferNASDAQ:THORSynthorx Inc
09/12/201908:16Dow Jones NewsSanofi to Buy Cancer Biotech Company Synthorx for $2.5 BillionNASDAQ:THORSynthorx Inc
09/12/201904:01Dow Jones NewsSanofi to Acquire Synthorx for $2.5 BillionNASDAQ:THORSynthorx Inc
13/11/201910:00GlobeNewswire Inc.Synthorx to Present at Upcoming Investor ConferencesNASDAQ:THORSynthorx Inc
05/11/201918:33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:THORSynthorx Inc
05/11/201918:05GlobeNewswire Inc.Synthorx Reports Third Quarter Financial ResultsNASDAQ:THORSynthorx Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:THOR

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
IDIV
Dividend
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
TOTS3
TOTVS ON
BOV
BPAC11
BTG PACTUAL UNT
BOV
CMIN3
CSN Mineracao S.A ON
BOV
HAGA3
HAGA ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
BRBI11
BR PARTNERS UNT N2
BOV
PETR4
PETROBRAS PN
BOV
PRIO3
PETRORIO ON
BOV
RCSL3
RECRUSUL ON
BOV
VVEO3
CM Hospitalar ON
BOV
HBOR3
HELBOR ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados